Summary:
Healthy adults aged 50 years and older are needed to participate in the study of a mRNA Influenza (FLU) vaccine. The study will evaluate the safety of the vaccine and its ability to generate an immune response against Influenza Types A & B.
Qualified volunteers may receive:
-Reimbursement for time and travel ($600+)
-51 weeks of study related treatment at no cost
Apply today to see if you qualify for this exciting new opportunity
Qualified Participants Must:
• Aged 50 and older
•
No Immuonocomprised status
•
Can not have had a Flu shot in the last 6 months
Qualified Participants May Receive:
- Reimbursement for time and travel ($600+)
- 51 weeks of study related treatment at no cost